CDKN2A (p16) mRNA decreased expression is a marker of poor prognosis in malignant high-grade glioma
Crossref DOI link: https://doi.org/10.1007/s13277-015-3480-5
Published Online: 2015-04-29
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sibin, M. K.
Bhat, Dhananjaya I.
Narasingarao, K. V. L.
Lavanya, Ch.
Chetan, G. K.
Text and Data Mining valid from 2015-04-29